F. Titti et al., LIVE ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS PREVENTS SUPERINFECTIONBY CLONED SIVMAC251 IN CYNOMOLGUS MONKEYS, Journal of General Virology, 78, 1997, pp. 2529-2539
The ability of a live attenuated simian immunodeficiency virus (SIV) t
o protect against challenge with cloned SIVmac251/BK28 was evaluated i
n four cynomolgus macaques. The intravenous infection of the C8 varian
t of the SIVmac251/32H vi rus, carrying an in-frame 12 bp deletion in
the nef gene, did not affect the CD4(+) and CD8(+) cell counts, and a
persistent infection associated with an extremely low virus burden in
peripheral blood mononuclear cells (PBMCs) was established, After 40 w
eeks, these monkeys were challenged intravenously with a 50 MID50 dose
of SIVmac251/BK28 virus grown on macaque cells, Four naive monkeys we
re infected as controls, Monkeys were monitored for 62 weeks following
challenge, Attempts to rescue virus from either PBMCs or bone marrow
from the C8-vaccinated monkeys were unsuccessful, but in two cases vir
us was re-isolated from lymph node cells, The presence of the SIV prov
irus with the C8 variant genotype maintaining its original nef deletio
n was shown by differential PCR in PBMCs, lymph nodes and bone marrow,
Furthermore, in contrast to the control monkeys, the vaccinated monke
ys showed normal levels for CD4(+) and CD8(+) cells, minimal lymphoid
hyperplasia and no clinical signs of infection, Our results confirm th
at vaccination with live attenuated virus can confer protection. This
appears to be dependent on the ability of the CS variant to establish
a persistent but attenuated infection which is necessary for inducing
an immune response, as suggested by the persistence of a strong immune
B cell memory and by the over-expression of interleukin (IL)-2, inter
feron-gamma and IL-15 mRNAs in PBMCs of CS-vaccinated monkeys but not
in those of control monkeys.